ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
154.03
-3.5700
-2.27%
盤後:
154.10
0.0700
+0.05%
19:59 EDT
成交量:
1,130.06萬
成交額:
17.39億
市值:
102.28億
市盈率:
8.45
高:
157.53
開:
157.08
低:
152.63
收:
157.60
52周最高:
169.89
52周最低:
93.26
股本:
6,640.00萬
流通股本:
6,640.00萬
量比:
1.47
換手率:
17.02%
股息:
0.57
股息率:
0.37%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
江蘇:鼓勵生物醫藥企業圍繞新產品研發、新技術應用、新業務佈局等積極增資擴產
智通财经
·
08/26
江蘇:發揮省戰新母基金引導作用,支持生物醫藥產業專項母基金直投創新藥械項目
智通财经
·
08/26
江蘇:推進「人工智能+醫療健康」行動
智通财经
·
08/26
江蘇:到2028年全省生物醫藥產業規模、創新藥械數量保持全國領先
智通财经
·
08/26
醫療板塊市場快訊:行業動態一覽
投资观察
·
08/26
巴克萊(BCS.US)任命Ramin Naji為亞太區醫療健康與房地產業務主管
智通财经
·
08/26
艾瑋得生物宣佈完成新一輪融資
智通财经
·
08/26
港股早評:三大指數高開,科網股普漲,生物醫藥股漲幅明顯
中金财经
·
08/26
港股生物醫藥股大漲,康希諾生物漲逾18%
新浪港股
·
08/26
醫療健康板塊市場綜述:市場快訊
投资观察
·
08/26
派格生物醫藥-B(02565)發布中期業績 研發開支1.1億元
智通财经
·
08/25
達安基因等成立合成生物科技公司
智通财经
·
08/25
據CNBC,聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。
格隆汇
·
08/24
據CNBC:聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。
智通财经
·
08/24
市場潛力大出海空間廣 生物醫藥價值重估在路上
智通财经
·
08/24
向新向優 加快建設現代產業之城
滚动播报
·
08/23
兩會聚焦丨向新向優 加快建設現代產業之城
石家庄发布
·
08/23
醫療保健板塊動態:市場快訊
投资观察
·
08/22
益方生物科技(上海)股份有限公司-B遞表港交所
格隆汇
·
08/21
天津最新職工平均工資+福利待遇標準公布!
滚动播报
·
08/21
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/XBI/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":154.03,"timestamp":1789502400000,"preClose":157.6,"halted":0,"volume":11300561,"hourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"delay":0,"changeRate":-0.02265228426395935,"floatShares":66400000,"shares":66400000,"eps":18.23,"marketStatus":"未開盤","change":-3.57,"latestTime":"09-15 16:00:00 EDT","open":157.08,"high":157.53,"low":152.63,"amount":1738536841.14598,"amplitude":0.031091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":157.6,"sharesOutstanding":63325000,"nav":157.586874,"aum":10743485169.21,"dividendRate":0.003684,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":157.17,"preClose":157.6,"latestTime":"09:29 EDT","volume":2906,"amount":456673.94784,"timestamp":1789478999999,"change":-0.43,"changeRate":-0.002728,"amplitude":0.005162},"postHourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"volumeRatio":1.474873,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"150.0","timestamp":1789502340274,"price":3.85,"volume":15000,"amount":5775000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"158.0","timestamp":1789502340274,"price":4.52,"volume":15000,"amount":6780000,"type":"-"}]},"impliedVol":0.319,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.474873,"shares":66400000,"dividePrice":0.5674,"high":157.53,"amplitude":0.031091,"preClose":157.6,"low":152.63,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.03,"eps":18.23,"divideRate":0.003684,"volume":11300561,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":161.93,"twentyDayClose":159.53,"sixtyDayClose":140.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662794272","title":"江蘇:鼓勵生物醫藥企業圍繞新產品研發、新技術應用、新業務佈局等積極增資擴產","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794272?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:44","pubTimestamp":1787737468,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662260794","title":"江蘇:發揮省戰新母基金引導作用,支持生物醫藥產業專項母基金直投創新藥械項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2662260794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662260794?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:44","pubTimestamp":1787737443,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662944767","title":"江蘇:推進「人工智能+醫療健康」行動","url":"https://stock-news.laohu8.com/highlight/detail?id=2662944767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662944767?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:42","pubTimestamp":1787737348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PBOT","VHT","TECY","VUSE","GK","02834","QDEC","QQQX","NJAN","TQQQ","NOCT","LCLG","NBDS","SQQQ","NAPR","KOMP","QLD","XBI","FWD","OGIG","QMAR","NJUL","LABU","AIFD","QQQ","AQGX","MVPS","QTOC","03034","TQQY","WPAI","NEWZ","AIBU","CHAT","QQQM","TARK","QID","ARTY","IXJ","MFIG","PSQ","AGIX","CPNQ","QSWN","AIQU","GPIQ","XLV","CWC","DQJN","QQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662941487","title":"江蘇:到2028年全省生物醫藥產業規模、創新藥械數量保持全國領先","url":"https://stock-news.laohu8.com/highlight/detail?id=2662941487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662941487?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:40","pubTimestamp":1787737240,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159893233","title":"醫療板塊市場快訊:行業動態一覽","url":"https://stock-news.laohu8.com/highlight/detail?id=1159893233","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159893233?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 16:25","pubTimestamp":1787732717,"startTime":"0","endTime":"0","summary":"0743 GMT——花旗研究在药明合联公布上半年业绩后,基于其强劲的增长可见性,继续维持对该股的看涨立场。分析师指出,这家医疗保健服务公司的管理层重申了2026年指引,预计2025年至2030年间收入复合年增长率将达30%-35%,同时提及包括里程碑费用在内的总积压订单同比增长了62%。该行将目标价由此前的73.00港元上调至93.00港元,并维持买入评级。该股目前下跌3.6%,报77.30港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","XBI","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662767102","title":"巴克萊(BCS.US)任命Ramin Naji為亞太區醫療健康與房地產業務主管","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767102","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662767102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 13:39","pubTimestamp":1787722750,"startTime":"0","endTime":"0","summary":"据悉,Ramin Naji将常驻香港,负责领导巴克莱在亚太地区的医疗健康及房地产板块业务,重点推动客户拓展、交易发起及执行。在汇报关系方面,Ramin Naji将在区域层面向巴克莱亚太区投资银行业务主管Avinash Thakur汇报,在职能层面则向全球医疗健康与地产业务集团主管Richard Landgarten汇报。加盟巴克莱前,Ramin Naji曾在德意志银行担任董事总经理及亚太区医疗健康业务主管。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","XLV","VHT","09979","159760","BK1148","BK4521","BK4550","BCS","XBI","BK4585","IXJ","REET","BK4588","BK4207","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662090769","title":"艾瑋得生物宣佈完成新一輪融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2662090769","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662090769?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 10:32","pubTimestamp":1787711566,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769800","title":"港股早評:三大指數高開,科網股普漲,生物醫藥股漲幅明顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769800","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 09:37","pubTimestamp":1787708221,"startTime":"0","endTime":"0","summary":"美伊局势缓和,美股三大指数集体收涨,市场静待英伟达财报。港股三大指数集体高开,恒指涨0.49%,国指涨0.65%,恒生科技指数涨0.75%。大型科网股集体上涨,京东涨近2%,阿里巴巴、美团涨1.3%,小米、百度、腾讯涨近1%;生物医药股涨幅明显,康希诺生物大涨13%,信达生物涨6.5%,海运股、餐饮股、航空股、半导体股齐涨。另外,煤炭股、石油股普跌。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260826/32347486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161726","399441","XBI","KCAI","BK4588","BK4585","VXUS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476606","title":"港股生物醫藥股大漲,康希諾生物漲逾18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476606","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662476606?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 09:37","pubTimestamp":1787708220,"startTime":"0","endTime":"0","summary":"模拟交易客户端港股生物医药股延续近期强势,康希诺生物大涨18%,信达生物绩后涨超11%,云顶新耀涨超8%,康方生物涨超6%,荣昌生物涨超5%。个股消息面上,康希诺生物宣布,子公司康希诺上海与德普世生物正式签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。本次合作面向全球,聚焦消化道实体瘤及罕见肿瘤治疗领域,覆盖早期研发、临床转化、注册申报及商业化等环节。目前,公司商业化产品矩阵已扩充至20款。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-08-26/doc-iniprcpw5390717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","KCAI","BK1515","VXUS","BK4581","BK1161","BK1191","161726","XBI","BK4588","06185","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127147911","title":"醫療健康板塊市場綜述:市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1127147911","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127147911?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 04:52","pubTimestamp":1787691172,"startTime":"0","endTime":"0","summary":"覆盖医疗健康领域的最新市场快讯。本资讯仅通过道琼斯通讯社于美东时间4:20、12:20及16:50独家发布。分析师同时警告,市场对此反应热烈,可能源于部分交易者误将该疫苗视作预防性疗法。Moderna股价当日大涨14%,报收158.10美元,在过去一个月内市值已近乎翻了三倍。该机构将Insmed的目标价从192美元上调至195美元,理由是该公司治疗非囊性纤维化支气管扩张症的Brinsupri疗法已获日本批准。Insmed股价当日收跌1.4%,报123.98美元,今年以来已累计下跌29%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","LABU","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782435","title":"派格生物醫藥-B(02565)發布中期業績 研發開支1.1億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782435?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 16:37","pubTimestamp":1787647040,"startTime":"0","endTime":"0","summary":"智通财经APP讯,派格生物医药-B 发布截至2025年6月30日止6个月中期业绩,该集团取得其他净亏损人民币1127万元,研发开支1.1亿元,每股亏损0.55元。报告期后,派达康已于多家医疗机构陆续开出首批商业化处方,进一步推进产品的临床应用及患者可及性。随着派达康首批商业化处方于全国范围内成功开出,该协议所规定的第二笔约港币4900万元权益金的所有条件已全部达成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","BK4581","BK4585","BK1161","399441","XBI","161726","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662022072","title":"達安基因等成立合成生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662022072","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662022072?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:01","pubTimestamp":1787619687,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4581","LNGR","GDOC","XBI","MEDX","IBBJ","SYNB","AGNG","IEIH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273978","title":"據CNBC,聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273978","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273978?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:08","pubTimestamp":1787569727,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["CGVV","BK4532","LU1162221912.USD","LU1267930227.SGD","IE00BFSS8Q28.SGD","LU0976567544.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","BK4559","BK4581","IE0002270589.USD","BK4131","IE00B19Z3581.USD","LU0149725797.USD","HULL","LU0320765489.SGD","VHT","UPS","LU0052756011.USD","LU0310800965.SGD","IE00B7KXQ091.USD","LU1894683348.USD","LU0211331839.USD","LU1430594728.SGD","BK4588","IE00BJJMRY28.SGD","LU1894683264.USD","SHPP","UPSG","DOCK","LU0320765646.SGD","BK4585","LU2237438978.USD","BK4550","NOBL","XBI","IYT","LU2133065610.SGD","LABU","IE00B19Z3B42.SGD","IE00BJJMRX11.SGD","LU0128525689.USD","LU0211326755.USD","SUPL","LU0070302665.USD","XLV","IE00BFSS7M15.SGD","IE0004445015.USD","LU0061475181.USD","LU0496365809.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661739272","title":"據CNBC:聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661739272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661739272?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:07","pubTimestamp":1787569640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SHPP","UPS","LU1585245621.USD","IE0004445015.USD","LU0310800965.SGD","BK4559","IE00B7SZLL34.SGD","LU0052756011.USD","NOBL","BK4550","LU0496365809.HKD","BK4585","IE00BFSS8Q28.SGD","LU0128525689.USD","LU1430594728.SGD","VHT","LU0976567544.SGD","IE00B19Z3581.USD","LU2133065610.SGD","SUPL","LU0149725797.USD","LABU","LU0211326839.USD","XLV","IE00B7KXQ091.USD","UPSG","LU0320765489.SGD","BK4534","LU1074936037.SGD","IE00BJJMRY28.SGD","IE00B19Z3B42.SGD","DOCK","LU1894683348.USD","BK4131","CGVV","LU0211326755.USD","IE00BFSS7M15.SGD","BK4588","LU0061475181.USD","BK4532","LU1162221912.USD","IYT","LU0208291251.USD","IE00BJJMRX11.SGD","LU1267930227.SGD","LU0070302665.USD","HULL","XBI","LU2237438978.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661499782","title":"市場潛力大出海空間廣 生物醫藥價值重估在路上","url":"https://stock-news.laohu8.com/highlight/detail?id=2661499782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661499782?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 07:20","pubTimestamp":1787527236,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217930","title":"向新向優 加快建設現代產業之城","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217930","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217930?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 11:51","pubTimestamp":1787457060,"startTime":"0","endTime":"0","summary":"市政协委员、石家庄高新区生物医药产业研究院院长高健表示。“建议加快建设燕赵电子信息实验室,打造京津冀电子信息产业创新高地。”市政协委员、市国资委党委书记、主任苏军献表示,将进一步深化国资国企改革,加快打造创新领先、功能突出、治理高效、充满活力的现代新国企,全面叫响石家庄国资国企新品牌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-23/doc-iniphnkw2590637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XBI","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661362217","title":"兩會聚焦丨向新向優 加快建設現代產業之城","url":"https://stock-news.laohu8.com/highlight/detail?id=2661362217","media":"石家庄发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661362217?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 10:18","pubTimestamp":1787451480,"startTime":"0","endTime":"0","summary":"市政协委员、石家庄高新区生物医药产业研究院院长高健表示。“建议加快建设燕赵电子信息实验室,打造京津冀电子信息产业创新高地。”市人大代表、石家庄四药有限公司党委书记史建会在调研中发现,建设与产业发展相匹配的数字人才队伍迫在眉睫。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-23/doc-iniphhay2670393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110499199","title":"醫療保健板塊動態:市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1110499199","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110499199?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 00:25","pubTimestamp":1787329551,"startTime":"0","endTime":"0","summary":"聚焦医疗保健领域的最新市场快讯,独家发布于道琼斯通讯社,更新时段为美国东部时间凌晨4:20、中午12:20及下午4:50。美国东部时间凌晨5:40——与加密货币挂钩的美股在盘前交易中延续涨势,比特币与以太坊的强劲攀升成为主要推手。她指出,Zydus Lifesciences在获得美国食品药品监督管理局批准后,即可推出其仿制吲哚菁绿产品。与此同时,Provepharm已率先在英国市场推出其“Zyogreen”产品,并将目光投向美国市场以寻求进一步的地域扩张。该股应声下挫7.4%,报0.69美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0886674414.USD","LU2237957902.USD","SG9999002414.USD","BK4588","LU1956131251.USD","GDLC","LU0029875118.USD","SG9999005177.SGD","LU0955648018.USD","LU0873338254.USD","SG9999011175.SGD","LU0169518387.USD","LU0345776255.USD","SG9999009443.AUD","LU2506951875.HKD","LU0823413587.USD","LU0577902454.USD","LU0577902371.SGD","LU0326948709.USD","LU0384037296.USD","SGXZ43160589.SGD","LU1211504680.USD","LU2257852520.SGD","BK6516","LU2506951958.HKD","LU0823397285.USD","SG9999001226.SGD","SG9999000459.SGD","LU0084288322.USD","LU0543330483.HKD","LU1130305938.SGD","LU1363072403.SGD","LU0675040207.SGD","LU0188438112.USD","LU3227948356.SGD","LU0950375773.USD","LU1634259391.SGD","NCIQ","SG9999013460.SGD","BK6523","SG9999002562.SGD","LU0011963245.USD","LU0823038988.USD","LU0315178854.USD","LU0955623706.USD","LU0630378429.USD","LU0823417653.USD","SG9999006266.SGD","STCE","LU0823413660.USD","SG9999002604.SGD","LU0261947096.USD","LU2506952097.USD","LU0320764755.SGD","SG9999001903.USD","LU0762540952.USD","BK4581","SG9999004360.SGD","LU0831103253.SGD","XLV","LU0210637038.USD","LABU","SG9999000475.SGD","SG9999001846.SGD","LU0865486749.SGD","LU0488056044.USD","LU0251143029.SGD","LU1497734951.SGD","CRPT","LU0532188223.SGD","SG9999004220.SGD","LU0882747503.HKD","SG9999003800.SGD","LU0048597586.USD","LU0192582467.USD","SG9999008742.SGD","LU0823039010.USD","IE00BGHQDM52.EUR","SG9999014492.USD","SGXZ16066938.SGD","LU1634259557.SGD","LU2237957811.SGD","SG9999013486.USD","BKCH","LU2238330802.EUR","LU1497733631.SGD","LU0165289439.USD","LU0672654166.SGD","LU0441851309.USD","LU1282649810.SGD","SG9999002406.SGD","LU0955669360.SGD","D05.SI","LU1504937902.USD","SG9999001135.SGD","LU2506952170.USD","LU2152927971.USD","BITW","IE00BKZH1Z71.USD","BK4585","SG9999001127.SGD","XBI","BITQ","LU0588545904.SGD","SG9999000343.SGD","DAPP","IE0031814969.USD","LU0878005551.USD","LU1282649067.USD","LU0898667661.SGD","LU1839390173.USD","SG9999014302.SGD","LU0048573645.USD","BK6112","LU0577902611.USD","LU0823397103.USD","LU0211331839.USD","SG9999007991.SGD","SGXZ27511609.SGD","LU0577902538.SGD","LU0441854154.USD","LU0261945553.USD","LU0588545730.USD","IE00BVYPNP33.GBP","SGXZ58947870.SGD","LU0588545490.SGD","IE00BVYPNQ40.USD","LU0577902298.EUR","LU0043850808.USD","SG9999003826.SGD","LU0061477393.USD","SG9999013353.USD","SG9999013478.USD","IE0003895053.USD","LU1497733557.USD","SG9999002620.SGD","LU0205439572.USD","LU0823417737.USD","LU0878004406.USD","SG9999016042.SGD","SGXZ24219693.SGD","LU1282649141.HKD","SG9999002679.SGD","SGXZ70427877.SGD","LU0971096721.USD","SGXZ51708014.SGD","LU0235996351.USD","LU0737861269.HKD","SG9999014484.SGD","LU0831093199.SGD","LU0096374516.USD","LU0251144936.SGD","LFGY","LU0128522157.USD","SGXZ91733576.SGD","LU1770036033.HKD","LU0345775950.USD","LU0648948544.HKD","LU1522347837.USD","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295929","title":"益方生物科技(上海)股份有限公司-B遞表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295929","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295929?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:58","pubTimestamp":1787320734,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159837","LNGR","MEDX","AGNG","BK4588","GDOC","SYNB","IEIH","BK4581","IBBJ","XBI","BK4585","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661578261","title":"天津最新職工平均工資+福利待遇標準公布!","url":"https://stock-news.laohu8.com/highlight/detail?id=2661578261","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661578261?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 17:43","pubTimestamp":1787305380,"startTime":"0","endTime":"0","summary":"答:2025年全市职工平均工资发布后,同步调整的职工有关保险、工资、福利待遇仍按历年政策,从2026年1月1日起执行。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-21/doc-iniparar1550862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","LABU","XLV","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}